Treatment of the schizophrenia prodrome: is it presently ethical?
about
Antipsychotic medication for early episode schizophreniaAntipsychotic medication for early episode schizophreniaWhat can triumphs and tribulations from drug research in Alzheimer's disease tell us about the development of psychotropic drugs in general?Research in people with psychosis risk syndrome: a review of the current evidence and future directionsEvaluating early preventive antipsychotic and antidepressant drug treatment in an infection-based neurodevelopmental mouse model of schizophrenia.Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disordersRisk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research.Prospective investigations of the prodromal state of schizophrenia: review of studies.Treatment history in the psychosis prodrome: characteristics of the North American Prodrome Longitudinal Study CohortClinical aspects of substance abuse in persons with schizophrenia.Early intervention in psychotic disorders: Challenges and relevance in the Indian context.Treating early psychosis: who, what, and when?Interaction of social role functioning and coping in people with recent-onset attenuated psychotic symptoms: a case study of three Chinese women at clinical high risk for psychosisThe catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes.Understanding the genesis of psychotic disorder: issues in the prediction and prophylaxis of those at 'ultra-high risk'.A brief taxometrics primer.Ethical concerns in schizophrenia research: looking back and moving forward.Ten good reasons to consider biological processes in prevention and intervention researchValidity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study.Treatment implications of the schizophrenia prodrome.The Singapore flagship programme in translational and clinical research in psychosis.Cognitive behavioral therapy in prodromal psychosis.Genealogy of instruments for prodrome evaluation of psychosis.The prodromal stage of psychotic illness: observation, detection or intervention?Early and broadly defined psychosis risk mental statesFactors associated with the prodromal progression of schizophrenia that influence the course of the illness.Ethical considerations when treating patients with schizophrenia.Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis.Early detection and intervention evaluation for people at high-risk of psychosis-2 (EDIE-2): trial rationale, design and baseline characteristics.
P2860
Q24236683-526752C3-0041-43BE-AF3F-A38AE37EB2ECQ24243660-3527F541-6C1E-4644-B22B-1F4C83B44774Q28083481-8E7E8A97-B762-4CA7-9DB3-A7370B92D3E2Q30475598-332A8D46-BDF3-4F86-B6F3-88BB985079FDQ30475712-C0295748-3170-405B-BF97-73E64407C912Q34095720-00C4BAC3-B621-4DF4-8476-BF0C4DA030F2Q34561567-00FE359F-3FBA-4C05-90E5-ED5520C34978Q34566772-238B22F8-AD7F-411C-8278-FE62349F34D4Q34727780-086213EA-74BE-4DC5-B1C8-81B358F0E0C4Q35084956-2170C82C-AFEC-4D63-81C0-E16ADAF31833Q35135578-A1B9F2E5-49D3-460D-9397-9249B8F4840AQ35236583-7F25FDCF-ADB3-44E4-BD1C-C1B407C34691Q35846759-2CBAC140-B6EC-458C-A4D9-4FF64C43B28AQ35860569-799CABB1-D1A0-4726-8058-1C6DAC095F42Q36292350-4D7C719B-9666-4BE8-8B19-6CF2F2DBD986Q37035256-551FFA99-96C6-47AE-BEAD-75D18A935A3EQ37075761-8C1F1764-8124-47EA-B66E-65DE51FD4D21Q37208934-B1F8CF40-5318-48E6-892C-92AFEC2F03D6Q37310198-BD4634AF-1364-4E2C-B442-85AE106C9628Q37839923-B8663532-CE02-4861-A4BE-A8BD33BAAEE7Q37950070-A31FF3EA-8741-4A77-9E59-B22B5856F556Q37975276-0FA4F4BA-EB47-4C52-A32F-843476CC6178Q38101557-EE54DDBA-BC9B-4D63-AC52-6DA8368F393AQ39775782-1DEB86F9-15EA-48B8-B749-CD7314D3ADA4Q39810959-9681A8BF-8A98-4FB6-9600-7C036A08B7B6Q40365810-CE645F78-BF68-49CB-B52E-6F7FD721B0DBQ42008097-33E3D41C-4569-4031-80C6-D6FA79D01589Q50719449-825320E6-234A-453B-9E7E-2F57D922DD1FQ51817400-F548112F-6B54-493E-B3B3-E957E2E1C4D9
P2860
Treatment of the schizophrenia prodrome: is it presently ethical?
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Treatment of the schizophrenia prodrome: is it presently ethical?
@ast
Treatment of the schizophrenia prodrome: is it presently ethical?
@en
Treatment of the schizophrenia prodrome: is it presently ethical?
@nl
type
label
Treatment of the schizophrenia prodrome: is it presently ethical?
@ast
Treatment of the schizophrenia prodrome: is it presently ethical?
@en
Treatment of the schizophrenia prodrome: is it presently ethical?
@nl
prefLabel
Treatment of the schizophrenia prodrome: is it presently ethical?
@ast
Treatment of the schizophrenia prodrome: is it presently ethical?
@en
Treatment of the schizophrenia prodrome: is it presently ethical?
@nl
P1476
Treatment of the schizophrenia prodrome: is it presently ethical?
@en
P2093
B A Cornblatt
P356
10.1016/S0920-9964(01)00236-5
P407
P50
P577
2001-08-01T00:00:00Z